BIOMARIN PHARMACEUTICAL INC Effective Income Tax Rate Reconciliation, Deduction, Percent
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Effective Income Tax Rate Reconciliation, Deduction, Percent of -0.90% for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-26.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductions · last filed 2013-02-26
- BIOMARIN PHARMACEUTICAL INC effective income tax rate reconciliation, deduction, percent for fiscal 2012 was -0.90%.
- BIOMARIN PHARMACEUTICAL INC effective income tax rate reconciliation, deduction, percent for fiscal 2011 was -1.30%.
- BIOMARIN PHARMACEUTICAL INC effective income tax rate reconciliation, deduction, percent for fiscal 2010 was -1.60%, a 101.15% decline from fiscal 2009.
- BIOMARIN PHARMACEUTICAL INC effective income tax rate reconciliation, deduction, percent for fiscal 2009 was 139.50%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Percent 12 month |
|---|---|
| 2012-12-31 | -0.90% 10-K · filed 2013-02-26 |
| 2011-12-31 | -1.30% 10-K · filed 2013-02-26 |
| 2010-12-31 | -1.60% 10-K · filed 2013-02-26 |
| 2009-12-31 | 139.50% 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |